# US 2013/0157314 A1 · Compositions Comprising A Polypeptide Having Cellulolytic Enhancing Activity And A Heterocyclic Compound And Uses Thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2013/0157314 A1
- Document ID: US20130157314A1
- Status: Published application
- Kind: A1
- Application number: 13/816,146
- Filed: 2011-08-05
- Published: 2013-06-20
- Earliest claimed: 2010-08-12
- Assignees: Novozymes, Inc.
- Inventors: Feng Xu; Matthew Sweeney; Jason Quinlan
- Web page: https://patentgrep.com/patent/US20130157314A1

## CPC

- C12P 19/14: produced by the action of a carbohydrase {(EC 3.2.x)}, e.g. by alpha-amylase {, e.g. by cellulase, hemicellulase}
- B01J 31/06: containing polymers {(organometallic polymers B01J31/123; polymer-bound organometallic complexes B01J31/165; coordination polymers B01J31/1691)}
- C12N 9/2402: {hydrolysing O- and S- glycosyl compounds (3.2.1)}
- C12N 9/2437: {Cellulases (3.2.1.4; 3.2.1.74; 3.2.1.91; 3.2.1.150)}
- C12N 9/2445: {Beta-glucosidase (3.2.1.21)}
- C12N 9/96: Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
- C12P 7/10: substrate containing cellulosic material
- C12P 7/14: Multiple stages of fermentation; Multiple types of microorganisms or re-use of microorganisms
- C12P 19/02: Monosaccharides (2-ketogulonic acid C12P7/60)
- C12Y 302/01004: Cellulase (3.2.1.4), i.e. endo-1,4-beta-glucanase
- C12Y 302/01021: Beta-glucosidase (3.2.1.21)
- C13K 1/02: obtained by saccharification of cellulosic materials (manufacture of fodder A23K10/32)
- C12P 2203/00: Fermentation products obtained from optionally pretreated or hydrolyzed cellulosic or lignocellulosic material as the carbon source
- Y02E 50/10: Biofuels, e.g. bio-diesel
- Y02P 20/52: using catalysts, e.g. selective catalysts
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- B01J: CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12Y: ENZYMES
- C13K: SACCHARIDES OBTAINED FROM NATURAL SOURCES OR BY HYDROLYSIS OF NATURALLY OCCURRING DISACCHARIDES, OLIGOSACCHARIDES OR POLYSACCHARIDES (chemically synthesised sugars or sugar derivatives C07H; polysaccharides, e.g. starch, derivatives thereof C08B; malt C12C; fermentation or enzyme-using processes for preparing compounds containing saccharide radicals C12P19/00; production of sucrose C13B)
- Y02E: REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
- Y02P: CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS

## Abstract

The present invention relates to compositions comprising: a polypeptide having cellulolytic enhancing activity and a heterocyclic compound. The present invention also relates to methods of using the compositions.

## Claims

### Claim 1

A composition comprising: (a) a polypeptide having cellulolytic enhancing activity and (b) a heterocyclic compound, wherein the combination of the polypeptide having cellulolytic enhancing activity and the heterocyclic compound enhances hydrolysis of a cellulosic material by a cellulolytic enzyme.

### Claim 2 (depends on 1)

The composition of claim 1, wherein the heterocyclic compound is a compound of formula (I) or (II):
wherein each bond indicated with a dashed line is single or double;
R1, R2, R3, R4, and R5 are independently hydrogen, halogen, ═O, —OH, —OR8, —CN, —NO2, —N(R9)(R10), —C(O)R20, —C(O)OR6, —C(O)NHR7, —OC(O)R11, —NHC(O)R12, —OC(O)OR13, —NHC(O)OR14, —OC(O)NHR15, —NHC(O)NHR16, —SO2R17, —SO2N(R18)(R19), —SR20, or an optionally substituted moiety selected from alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkyl-alkyl, heterocycloalkyl, heterocycloalkyl-alkyl, aryl, aralkyl, heteroaryl, and heteroaralkyl;
R6, R7, R8, R9, R10, R11, R12, R13, R14, R15, R16, R18, R19, R20, and R21 are independently hydrogen, or an optionally substituted moiety selected from alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkyl-alkyl, heterocycloalkyl, heterocycloalkyl-alkyl, aryl, aralkyl, heteroaryl, and heteroaralkyl; and
R17 is an optionally substituted moiety selected from alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkyl-alkyl, heterocycloalkyl, heterocycloalkyl-alkyl, aryl, aralkyl, heteroaryl, and heteroaralkyl; and
wherein each pair of R1 and R2, R2 and R3, R3 and R4, and R4 and R5 may combine to form an optionally substituted fused ring;
or a salt or solvate thereof.

### Claim 3 (depends on 2)

The composition of claim 2, wherein the heterocyclic compound is a compound of formula (I-A), (I-B), or (I-C):
wherein R1, R2, R3, and R4 are as defined in the preceding claims; or a salt or solvate thereof.

### Claim 4 (depends on 2)

The composition of claim 2, wherein the heterocyclic compound is a compound of formula (I-D), (I-E), (I-F), or (I-G):
wherein R1, R2, R3, and R4 are as defined in the preceding claims; or a salt or solvate thereof.

### Claim 5 (depends on 2)

The composition of claim 2, wherein the heterocyclic compound is a compound of formula (I-A), (I-B), or (I-C):
wherein R1, R2, R3, R4, and R5 are as defined in the preceding claims; or a salt or solvate thereof.

### Claim 6 (depends on 2)

The composition of claim 2, wherein the heterocyclic compound is selected from the group consisting of: (I-1): (1,2-dihydroxyethyl)-3,4-dihydroxyfuran-2(5H)-one; (I-2): 4-hydroxy-5-methyl-3-furanone; (I-3): 5-hydroxy-2(5H)-furanone; (I-4): [1,2-dihydroxyethyl]furan-2,3,4(5H)-trione; (I-5): α-hydroxy-γ-butyrolactone; (I-6): ribonic γ-lactone; (I-7): glucuronic acid γ-lactone; (I-8): dihydrobenzofuran; (I-9): 5-(hydroxymethyl)furfural; (I-10): furoin; (I-11): 2(5H)-furanone; (II-1): gluconic acid δ-lactone; (II-2): 4-hydroxycoumarin; (II-3): 5,6-dihydro-2H-pyran-2-one; (II-4): 5,6-dihydro-4-hydroxy-6-methyl-2H-pyran-2-one; (II-5): 1,5-anhydro-2-deoxy-arabino-hex-1-enitol; and (II-6): 3-deoxy-erythro-hexosulose; 3-hydroxy-5-methylisoxazole; or a salt or solvate thereof.

### Claim 7 (depends on 1)

The composition of claim 1, which further comprises (c) one or more enzymes selected from the group consisting of a cellulase, a hemicellulase, an esterase, an expansin, a laccase, a ligninolytic enzyme, a pectinase, a peroxidase, a protease, and a swollenin.

### Claim 8

A method for degrading or converting a cellulosic material, comprising: treating the cellulosic material with an enzyme composition in the presence of a polypeptide having cellulolytic enhancing activity and a heterocyclic compound, wherein the combination of the polypeptide having cellulolytic enhancing activity and the heterocyclic compound enhances hydrolysis of the cellulosic material by the enzyme composition.

### Claim 9 (depends on 8)

The method of claim 8, further comprising recovering the degraded cellulosic material.

### Claim 10 (depends on 8)

The method of claim 8, wherein the enzyme composition comprises one or more enzymes selected from the group consisting of a cellulase, a hemicellulase, an esterase, an expansin, a laccase, a ligninolytic enzyme, a pectinase, a peroxidase, a protease, and a swollenin.

### Claim 11

A method for producing a fermentation product, comprising:
(a) saccharifying a cellulosic material with an enzyme composition in the presence of a polypeptide having cellulolytic enhancing activity and a heterocyclic compound, wherein the combination of the polypeptide having cellulolytic enhancing activity and the heterocyclic compound enhances hydrolysis of the cellulosic material by the enzyme composition;
(b) fermenting the saccharified cellulosic material with one or more fermenting microorganisms to produce the fermentation product; and
(c) recovering the fermentation product from the fermentation.

### Claim 12 (depends on 11)

The method of claim 11, wherein the enzyme composition comprises one or more enzymes selected from the group consisting of a cellulase, a hemicellulase, an esterase, an expansin, a laccase, a ligninolytic enzyme, a pectinase, a peroxidase, a protease, and a swollenin.

### Claim 13

A method of fermenting a cellulosic material, comprising: fermenting the cellulosic material with one or more fermenting microorganisms, wherein the cellulosic material is saccharified with an enzyme composition in the presence of a polypeptide having cellulolytic enhancing activity and a heterocyclic compound, wherein the combination of the polypeptide having cellulolytic enhancing activity and the heterocyclic compound enhances hydrolysis of the cellulosic material by the enzyme composition.

### Claim 14 (depends on 13)

The method of claim 13, wherein the enzyme composition comprises one or more enzymes selected from the group consisting of a cellulase, a hemicellulase, an esterase, an expansin, a laccase, a ligninolytic enzyme, a pectinase, a peroxidase, a protease, and a swollenin.

### Claim 15 (depends on 13)

The method of claim 13, wherein the fermenting of the cellulosic material produces a fermentation product.

### Claim 16 (depends on 15)

The method of claim 15, further comprising recovering the fermentation product from the fermentation.

### Claim 17 (depends on 8)

The method of claim 8, wherein the heterocyclic compound is a compound of formula (I) or (II):
wherein each bond indicated with a dashed line is single or double;
R1, R2, R3, R4, and R5 are independently hydrogen, halogen, ═O, —OH, —OR8, —CN, —NO2, —N(R9)(R10), —C(O)R20, —C(O)OR6, —C(O)NHR7, —OC(O)R11, —NHC(O)R12, —OC(O)OR13, —NHC(O)OR14, —OC(O)NHR15, —NHC(O)NHR16, —SO2R17, —SO2N(R18)(R19), —SR20, or an optionally substituted moiety selected from alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkyl-alkyl, heterocycloalkyl, heterocycloalkyl-alkyl, aryl, aralkyl, heteroaryl, and heteroaralkyl;
R6, R7, R8, R9, R10, R11, R12, R13, R14, R15, R16, R18, R19, R20, and R21 are independently hydrogen, or an optionally substituted moiety selected from alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkyl-alkyl, heterocycloalkyl, heterocycloalkyl-alkyl, aryl, aralkyl, heteroaryl, and heteroaralkyl; and
R17 is an optionally substituted moiety selected from alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkyl-alkyl, heterocycloalkyl, heterocycloalkyl-alkyl, aryl, aralkyl, heteroaryl, and heteroaralkyl; and
wherein each pair of R1 and R2, R2 and R3, R3 and R4, and R4 and R5 may combine to form an optionally substituted fused ring;
or a salt or solvate thereof.

### Claim 18 (depends on 17)

The method of claim 17, wherein the heterocyclic compound is a compound of formula (I-A), (I-B), or (I-C):
wherein R1, R2, R3, and R4 are as defined in the preceding claims; or a salt or solvate thereof.

### Claim 19 (depends on 17)

The method of claim 17, wherein the heterocyclic compound is a compound of formula (I-D), (I-E), (I-F), or (I-G):
wherein R1, R2, R3, and R4 are as defined in the preceding claims; or a salt or solvate thereof.

### Claim 20 (depends on 17)

The method of claim 17, wherein the heterocyclic compound is a compound of formula (I-A), (I-B), or (I-C):
wherein R1, R2, R3, R4, and R5 are as defined in the preceding claims; or a salt or solvate thereof.

### Claim 21 (depends on 17)

The method of claim 17, wherein the heterocyclic compound is selected from the group consisting of: (I-1): (1,2-dihydroxyethyl)-3,4-dihydroxyfuran-2(5H)-one; (I-2): 4-hydroxy-5-methyl-3-furanone; (I-3): 5-hydroxy-2(5H)-furanone; (I-4): [1,2-dihydroxyethyl]furan-2,3,4(5H)-trione; (I-5): α-hydroxy-γ-butyrolactone; (I-6): ribonic γ-lactone; (I-7): glucuronic acid γ-lactone; (I-8): dihydrobenzofuran; (I-9): 5-(hydroxymethyl)furfural; (I-10): furoin; (I-11): 2(5H)-furanone; (II-1): gluconic acid δ-lactone; (II-2): 4-hydroxycoumarin; (II-3): 5,6-dihydro-2H-pyran-2-one; (II-4): 5,6-dihydro-4-hydroxy-6-methyl-2H-pyran-2-one; (II-5): 1,5-anhydro-2-deoxy-arabino-hex-1-enitol; and (II-6): 3-deoxy-erythro-hexosulose; 3-hydroxy-5-methylisoxazole; or a salt or solvate thereof.

### Claim 22 (depends on 11)

The composition of claim 11, wherein the heterocyclic compound is a compound of formula (I) or (II):
wherein each bond indicated with a dashed line is single or double;
R1, R2, R3, R4, and R5 are independently hydrogen, halogen, ═O, —OH, —OR8, —CN, —NO2, —N(R9)(R10), —C(O)R20, —C(O)OR6, —C(O)NHR7, —OC(O)R11, —NHC(O)R12, —OC(O)OR13, —NHC(O)OR14, —OC(O)NHR15, —NHC(O)NHR16, —SO2R17, —SO2N(R18)(R19), —SR20, or an optionally substituted moiety selected from alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkyl-alkyl, heterocycloalkyl, heterocycloalkyl-alkyl, aryl, aralkyl, heteroaryl, and heteroaralkyl;
R6, R7, R8, R9, R10, R11, R12, R13, R14, R15, R16, R18, R19, R20, and R21 are independently hydrogen, or an optionally substituted moiety selected from alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkyl-alkyl, heterocycloalkyl, heterocycloalkyl-alkyl, aryl, aralkyl, heteroaryl, and heteroaralkyl; and
R17 is an optionally substituted moiety selected from alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkyl-alkyl, heterocycloalkyl, heterocycloalkyl-alkyl, aryl, aralkyl, heteroaryl, and heteroaralkyl; and
wherein each pair of R1 and R2, R2 and R3, R3 and R4, and R4 and R5 may combine to form an optionally substituted fused ring;
or a salt or solvate thereof.

### Claim 23 (depends on 22)

The method of claim 22, wherein the heterocyclic compound is selected from the group consisting of: (I-1): (1,2-dihydroxyethyl)-3,4-dihydroxyfuran-2(5H)-one; (I-2): 4-hydroxy-5-methyl-3-furanone; (I-3): 5-hydroxy-2(5H)-furanone; (I-4): [1,2-dihydroxyethyl]furan-2,3,4(5H)-trione; (I-5): α-hydroxy-γ-butyrolactone; (I-6): ribonic γ-lactone; (I-7): glucuronic acid γ-lactone; (I-8): dihydrobenzofuran; (I-9): 5-(hydroxymethyl)furfural; (I-10): furoin; (I-11): 2(5H)-furanone; (II-1): gluconic acid δ-lactone; (II-2): 4-hydroxycoumarin; (II-3): 5,6-dihydro-2H-pyran-2-one; (II-4): 5,6-dihydro-4-hydroxy-6-methyl-2H-pyran-2-one; (II-5): 1,5-anhydro-2-deoxy-arabino-hex-1-enitol; and (II-6): 3-deoxy-erythro-hexosulose; 3-hydroxy-5-methylisoxazole; or a salt or solvate thereof.

### Claim 24 (depends on 13)

The composition of claim 13, wherein the heterocyclic compound is a compound of formula (I) or (II):
wherein each bond indicated with a dashed line is single or double;
R1, R2, R3, R4, and R5 are independently hydrogen, halogen, ═O, —OH, —OR8, —CN, —NO2, —N(R9)(R10), —C(O)R20, —C(O)OR6, —C(O)NHR7, —OC(O)R11, —NHC(O)R12, —OC(O)OR13, —NHC(O)OR14, —OC(O)NHR15, —NHC(O)NHR16, —SO2R17, —SO2N(R18)(R19), —SR20, or an optionally substituted moiety selected from alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkyl-alkyl, heterocycloalkyl, heterocycloalkyl-alkyl, aryl, aralkyl, heteroaryl, and heteroaralkyl;
R6, R7, R8, R9, R10, R11, R12, R13, R14, R15, R16, R18, R19, R20, and R21 are independently hydrogen, or an optionally substituted moiety selected from alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkyl-alkyl, heterocycloalkyl, heterocycloalkyl-alkyl, aryl, aralkyl, heteroaryl, and heteroaralkyl; and
R17 is an optionally substituted moiety selected from alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkyl-alkyl, heterocycloalkyl, heterocycloalkyl-alkyl, aryl, aralkyl, heteroaryl, and heteroaralkyl; and
wherein each pair of R1 and R2, R2 and R3, R3 and R4, and R4 and R5 may combine to form an optionally substituted fused ring;
or a salt or solvate thereof.

### Claim 25 (depends on 24)

The method of claim 24, wherein the heterocyclic compound is selected from the group consisting of: (I-1): (1,2-dihydroxyethyl)-3,4-dihydroxyfuran-2(5H)-one; (I-2): 4-hydroxy-5-methyl-3-furanone; (I-3): 5-hydroxy-2(5H)-furanone; (I-4): [1,2-dihydroxyethyl]furan-2,3,4(5H)-trione; (I-5): α-hydroxy-γ-butyrolactone; (I-6): ribonic γ-lactone; (I-7): glucuronic acid γ-lactone; (I-8): dihydrobenzofuran; (I-9): 5-(hydroxymethyl)furfural; (I-10): furoin; (I-11): 2(5H)-furanone; (II-1): gluconic acid δ-lactone; (II-2): 4-hydroxycoumarin; (II-3): 5,6-dihydro-2H-pyran-2-one; (II-4): 5,6-dihydro-4-hydroxy-6-methyl-2H-pyran-2-one; (II-5): 1,5-anhydro-2-deoxy-arabino-hex-1-enitol; and (II-6): 3-deoxy-erythro-hexosulose; 3-hydroxy-5-methylisoxazole; or a salt or solvate thereof.
